Assessment of the Prevalence of the Use of Nasal Decongestants Among the General Population in Saudi Arabia
- PMID: 36579209
- PMCID: PMC9790230
- DOI: 10.7759/cureus.31892
Assessment of the Prevalence of the Use of Nasal Decongestants Among the General Population in Saudi Arabia
Abstract
Background A topical nasal decongestant (NDC) is widely prescribed in ENT practice and used as self-medication because it is available over the counter, which makes it an easily accessible medication. Due to its common and long-term use, it is associated with serious nasal complications. It is commonly self-administrated in many otolaryngology diseases like the common cold, sinusitis, and acute or chronic rhinitis. The long-term usage of nasal decongestants is associated with significantly increased side effects. Aim To assess the prevalence of the usage of nasal decongestants among the general population in Saudi Arabia ad the pattern of its use. Methodology A questionnaire-based, cross-sectional survey was applied to level all available populations in Saudi Arabia. Participants with ages aged 10 to 60 years old in Saudi Arabia were invited to participate in the survey. Data were collected from participants using a predesigned online questionnaire. The questionnaire included the participant's demographic data, NDC use, and pattern of use. The questionnaire was uploaded online by researchers and their friends using social media platforms. Results A total of 1456 participants completed the study questionnaire. Participants ages ranged from 10 to 60 years with a mean age of 26.9 ± 12.4 years old. Exact 585 (40.2%) participants were males and 1270 (87.2%) were from urban regions. A total of 657 (45.1%) respondents reported using nasal decongestants while 799 (54.9%) did not use NDC. As for the duration of use, 70.8% used NDC for less than five days and 13.5% used it for 5-15 days. The most reported causes of using NDC were nasal obstruction (62.7%) and common cold (25.7%). Conclusions In conclusion, the study revealed that the frequency of using nasal decongestants was common (45.1%) in the study. More efforts should be paid to improve public awareness regarding indications, duration of use, and method of using nasal decongestants to avoid rebound reactions that may affect patients' daily life activities.
Keywords: nasal congestion; nasal decongestants; pattern of use; population; prevalence; saudi arabia; utilization.
Copyright © 2022, Alharthi et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Pharmacists' Attitudes Towards Long-Term Use of Nasal Decongestants: A Cross-Sectional Study.J Multidiscip Healthc. 2024 Mar 13;17:1079-1090. doi: 10.2147/JMDH.S451835. eCollection 2024. J Multidiscip Healthc. 2024. PMID: 38505655 Free PMC article.
-
Utilization Pattern and Related Knowledge of Nasal Decongestants Among the General Population in Al-Qunfudah Governorate, Saudi Arabia: A Community-Based Cross-Sectional Study.Cureus. 2024 Jan 26;16(1):e53006. doi: 10.7759/cureus.53006. eCollection 2024 Jan. Cureus. 2024. PMID: 38406038 Free PMC article.
-
Awareness of the Unaizah populations in Al-Qassim province in Saudi Arabia regarding nasal decongestant use for allergic rhinitis and their side effect.J Family Med Prim Care. 2022 Mar;11(3):1070-1076. doi: 10.4103/jfmpc.jfmpc_1258_21. Epub 2022 Mar 10. J Family Med Prim Care. 2022. PMID: 35495803 Free PMC article.
-
Rebound congestion and rhinitis medicamentosa: nasal decongestants in clinical practice. Critical review of the literature by a medical panel.Eur Ann Otorhinolaryngol Head Neck Dis. 2013 Jun;130(3):137-44. doi: 10.1016/j.anorl.2012.09.005. Epub 2013 Feb 1. Eur Ann Otorhinolaryngol Head Neck Dis. 2013. PMID: 23375990 Review.
-
Effects of intranasal xylometazoline, alone or in combination with ipratropium, in patients with common cold.Curr Med Res Opin. 2010 Apr;26(4):889-99. doi: 10.1185/03007991003648015. Curr Med Res Opin. 2010. PMID: 20151787 Review.
Cited by
-
Pharmacists' Attitudes Towards Long-Term Use of Nasal Decongestants: A Cross-Sectional Study.J Multidiscip Healthc. 2024 Mar 13;17:1079-1090. doi: 10.2147/JMDH.S451835. eCollection 2024. J Multidiscip Healthc. 2024. PMID: 38505655 Free PMC article.
-
Variants of rhinitis medicamentosa treatment: a systematic review.Eur Arch Otorhinolaryngol. 2025 Apr 2. doi: 10.1007/s00405-025-09344-6. Online ahead of print. Eur Arch Otorhinolaryngol. 2025. PMID: 40175814 Review.
-
Utilization Pattern and Related Knowledge of Nasal Decongestants Among the General Population in Al-Qunfudah Governorate, Saudi Arabia: A Community-Based Cross-Sectional Study.Cureus. 2024 Jan 26;16(1):e53006. doi: 10.7759/cureus.53006. eCollection 2024 Jan. Cureus. 2024. PMID: 38406038 Free PMC article.
-
Moving Towards an Integrated Approach to Allergic Rhinitis Management: ARIA and EUFOREA Guidelines Similarities and Differences.Curr Allergy Asthma Rep. 2025 Jul 24;25(1):30. doi: 10.1007/s11882-025-01212-x. Curr Allergy Asthma Rep. 2025. PMID: 40702351 Review.
References
-
- Chapter 2: nasal obstruction. Osborn JL, Sacks R. Am J Rhinol Allergy. 2013;27 Suppl 1:0–8. - PubMed
-
- Treatment of congestion in upper respiratory diseases. Meltzer EO, Caballero F, Fromer LM, Krouse JH, Scadding G. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2866555/ Int J Gen Med. 2010;3:69–91. - PMC - PubMed
-
- Allergic rhinitis in children and adolescents. Schuler IV CF, Montejo JM. Immunol Allergy Clin North Am. 2021;41:613–625. - PubMed
-
- Successful treatment of the erythema and flushing of rosacea using a topically applied selective alpha1-adrenergic receptor agonist, oxymetazoline. Shanler SD, Ondo AL. Arch Dermatol. 2007;143:1369–1371. - PubMed
-
- Rhinitis medicamentosa. Ramey JT, Bailen E, Lockey RF. http://www.jiaci.org/issues/vol16issue03/1.pdf J Invest Allerg Clin Immunol. 2006;16:148. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous